Letter to the editor RE: Fulford et al., 2021 ‘A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2’

por Lake, Douglas F., Roeder, Alexa J., Seit-Nebi, Alim, Gonzalez-Moa, Maria J, Svarovsky, Sergei
Publicado 2022

Invariant amino acids essential for decoding function of polypeptide release factor eRF1

por Kolosov, Petr, Frolova, Ludmila, Seit-Nebi, Alim, Dubovaya, Vera, Kononenko, Artem, Oparina, Nina, Justesen, Just, Efimov, Alexandr, Kisselev, Lev
Publicado 2005

Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses

por Roeder, Alexa J., Koehler, Megan A., Jasbi, Paniz, McKechnie, Davis, Vanderhoof, John, Edwards, Baylee A., Gonzalez-Moa, Maria J., Seit-Nebi, Alim, Svarovsky, Sergei A., Lake, Douglas F.
Publicado 2022

Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders

por Lake, Douglas F., Roeder, Alexa J., Gonzalez-Moa, Maria J., Koehler, Megan, Kaleta, Erin, Jasbi, Paniz, Vanderhoof, John, McKechnie, Davis, Forman, Jack, Edwards, Baylee A., Seit-Nebi, Alim, Svarovsky, Sergei
Publicado 2022

Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2

por Lake, Douglas F., Roeder, Alexa J., Kaleta, Erin, Jasbi, Paniz, Pfeffer, Kirsten, Koelbela, Calvin, Periasamy, Sivakumar, Kuzmina, Natalia, Bukreyev, Alexander, Grys, Thomas E., Wu, Liang, Mills, John R, McAulay, Kathrine, Gonzalez-Moa, Maria, Seit-Nebi, Alim, Svarovsky, Sergei
Publicado 2021